학술논문
890PEverolimus as first-line or after cytokine therapy in patients with metastatic recurrent and/or unresectable renal cell carcinoma (RCC) (EVERMORE).
Document Type
Article
Author
Source
Subject
*RENAL cell carcinoma
Language
ISSN
0923-7534